Page last updated: 2024-09-05

sc 41661a and n-formylmethionine leucyl-phenylalanine

sc 41661a has been researched along with n-formylmethionine leucyl-phenylalanine in 1 studies

Compound Research Comparison

Studies
(sc 41661a)
Trials
(sc 41661a)
Recent Studies (post-2010)
(sc 41661a)
Studies
(n-formylmethionine leucyl-phenylalanine)
Trials
(n-formylmethionine leucyl-phenylalanine)
Recent Studies (post-2010) (n-formylmethionine leucyl-phenylalanine)
8006,71653356

Protein Interaction Comparison

ProteinTaxonomysc 41661a (IC50)n-formylmethionine leucyl-phenylalanine (IC50)
fMet-Leu-Phe receptorHomo sapiens (human)0.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kocan, GP; Mueller, RA; Nakao, A; Partis, RA; Smith, WG1

Other Studies

1 other study(ies) available for sc 41661a and n-formylmethionine leucyl-phenylalanine

ArticleYear
Contrasting effects of two arachidonate 5-lipoxygenase inhibitors on formyl-methionyl-leucyl-phenylalanine (fMLP) and complement fragment 5a induced human neutrophil superoxide generation.
    Biochemical pharmacology, 1994, Mar-15, Volume: 47, Issue:6

    Topics: Acetates; Amides; Animals; Complement C5a; Humans; Lipoxygenase Inhibitors; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phenols; Pyridines; Rats; Superoxides; Tumor Cells, Cultured

1994